Symbols / HSCS
HSCS Chart
About
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 8.93M |
| Enterprise Value | 7.86M | Income | -9.04M | Sales | 8.67K |
| Book/sh | 1.36 | Cash/sh | 0.61 | Dividend Yield | — |
| Payout | 0.00% | Employees | 15 | IPO | — |
| P/E | — | Forward P/E | -0.88 | PEG | — |
| P/S | 1030.20 | P/B | 2.06 | P/C | — |
| EV/EBITDA | -0.96 | EV/Sales | 906.32 | Quick Ratio | 1.25 |
| Current Ratio | 2.42 | Debt/Eq | 20.95 | LT Debt/Eq | — |
| EPS (ttm) | -6.56 | EPS next Y | -3.19 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-12-15 16:00 | ROA | -74.78% |
| ROE | -220.42% | ROIC | — | Gross Margin | 57.92% |
| Oper. Margin | -857.13% | Profit Margin | 0.00% | Shs Outstand | 3.18M |
| Shs Float | 3.06M | Short Float | 1.36% | Short Ratio | 1.08 |
| Short Interest | — | 52W High | 6.47 | 52W Low | 2.01 |
| Beta | 2.54 | Avg Volume | 45.40K | Volume | 7.05K |
| Target Price | $10.60 | Recom | None | Prev Close | $2.83 |
| Price | $2.81 | Change | -0.71% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$10.60
Mean price target
2. Current target
$2.81
Latest analyst target
3. DCF / Fair value
$-24.45
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.81
Low
$9.20
High
$12.00
Mean
$10.60
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-12-22 | main | Ascendiant Capital | Buy → Buy | $9 |
| 2025-10-01 | main | Ascendiant Capital | Buy → Buy | $9 |
| 2025-03-18 | main | Ascendiant Capital | Buy → Buy | $14 |
| 2024-12-18 | reit | Maxim Group | Buy → Buy | $12 |
| 2024-09-23 | reit | Ascendiant Capital | Buy → Buy | $15 |
| 2023-01-30 | init | Ascendiant Capital | — → Buy | $3 |
| 2022-12-19 | main | Maxim Group | — → Buy | $3 |
| 2022-11-09 | init | Maxim Group | — → Buy | $8 |
| 2022-08-08 | init | Benchmark | — → Speculative Buy | $8 |
- UK university bets on AI ECG to train future NHS heart specialists - Stock Titan hu, 05 Feb 2026 08
- HeartSciences Inc. (HSCS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Nasdaq ue, 21 Oct 2025 07
- HeartSciences Inc. Reports Second Quarter Fiscal 2026 Financial Results and Progress on MyoVista Insights and wavECG Device Submissions - Quiver Quantitative Mon, 15 Dec 2025 08
- Can HeartSciences Stock Recover If Markets Fall? - Trefis Mon, 22 Dec 2025 08
- New Highs: Whats the beta of HSCS stock - Weekly Risk Summary & Weekly Return Optimization Alerts - baoquankhu1.vn ue, 24 Feb 2026 13
- HeartSciences approves indemnification agreements for directors and officers - Investing.com ue, 16 Dec 2025 08
- HeartSciences (Nasdaq: HSCS) separates device, AI-ECG FDA paths - Stock Titan Mon, 15 Dec 2025 08
- HeartSciences Partners with University of the West of England to Establish Exclusive ECG Education and Technology Reference Center - Quiver Quantitative hu, 05 Feb 2026 08
- Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform - Yahoo Finance Mon, 08 Dec 2025 08
- HeartSciences Inc. (HSCS) - Zacks Investment Research Sat, 11 Jun 2022 16
- HeartSciences regains compliance with Nasdaq minimum equity requirement - Investing.com Wed, 17 Sep 2025 07
- Blood across our lifetimes: An age-specific ‘atlas’ tells a dynamic story - Boston Children's Answers Fri, 03 Jan 2025 08
- HeartSciences (HSCS) Stock Forecast and Price Target 2026 - MarketBeat hu, 16 May 2024 17
- Special Delivery Nanoparticle Sidesteps the ‘Middlemen’ - Georgia Institute of Technology Sat, 21 Dec 2024 08
- HSCS Stock Price and Chart — NASDAQ:HSCS - TradingView ue, 14 Jun 2022 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 70000 | — | — | Stock Award(Grant) at price 0.00 per share. | SIMPSON ANDREW | Chief Executive Officer | — | 2025-11-28 00:00:00 | D |
| 1 | 4416 | 15621 | — | Sale at price 3.54 per share. | HILZ MARK T | Chief Operating Officer | — | 2025-07-29 00:00:00 | D |
Financials
| Line Item | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -8.14M | -6.16M | -5.98M | -4.68M |
| TotalUnusualItems | 0.00 | 250.20K | 251.86K | |
| TotalUnusualItemsExcludingGoodwill | 0.00 | 250.20K | 251.86K | |
| NetIncomeFromContinuingOperationNetMinorityInterest | -8.77M | -6.61M | -6.35M | -4.83M |
| ReconciledDepreciation | 127.96K | 95.13K | 135.45K | 26.57K |
| ReconciledCostOfRevenue | 1.88K | 6.08K | 2.80K | 7.89K |
| EBITDA | -8.14M | -6.16M | -5.98M | -4.43M |
| EBIT | -8.26M | -6.25M | -6.11M | -4.46M |
| NetInterestIncome | -500.45K | -354.08K | -243.17K | -371.62K |
| InterestExpense | 500.45K | 354.08K | 243.17K | 371.62K |
| NormalizedIncome | -8.77M | -6.61M | -6.35M | -5.08M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -8.77M | -6.61M | -6.35M | -4.83M |
| TotalExpenses | 8.36M | 6.32M | 6.12M | 4.72M |
| TotalOperatingIncomeAsReported | -8.35M | -6.31M | -6.11M | -4.71M |
| DilutedAverageShares | 938.26K | 352.52K | 101.18K | 81.12K |
| BasicAverageShares | 938.26K | 352.52K | 101.18K | 81.12K |
| DilutedEPS | -9.34 | -18.74 | -62.80 | -59.52 |
| BasicEPS | -9.34 | -18.74 | -62.80 | -59.52 |
| DilutedNIAvailtoComStockholders | -8.77M | -6.61M | -6.35M | -4.83M |
| NetIncomeCommonStockholders | -8.77M | -6.61M | -6.35M | -4.83M |
| NetIncome | -8.77M | -6.61M | -6.35M | -4.83M |
| NetIncomeIncludingNoncontrollingInterests | -8.77M | -6.61M | -6.35M | -4.83M |
| NetIncomeContinuousOperations | -8.77M | -6.61M | -6.35M | -4.83M |
| PretaxIncome | -8.77M | -6.61M | -6.35M | -4.83M |
| OtherIncomeExpense | 87.80K | 54.64K | 1.85K | 252.76K |
| OtherNonOperatingIncomeExpenses | 87.80K | 54.64K | 1.85K | 2.56K |
| SpecialIncomeCharges | 0.00 | 250.20K | 251.86K | |
| GainOnSaleOfPPE | 0.00 | 1.66K | ||
| OtherSpecialCharges | -250.20K | -250.20K | ||
| NetNonOperatingInterestIncomeExpense | -500.45K | -354.08K | -243.17K | -371.62K |
| InterestExpenseNonOperating | 500.45K | 354.08K | 243.17K | 371.62K |
| OperatingIncome | -8.35M | -6.31M | -6.11M | -4.71M |
| OperatingExpense | 8.36M | 6.32M | 6.12M | 4.72M |
| ResearchAndDevelopment | 4.39M | 2.88M | 2.46M | 3.00M |
| SellingGeneralAndAdministration | 3.97M | 3.44M | 3.65M | 1.71M |
| GrossProfit | 2.47K | 12.52K | 2.35K | 6.48K |
| CostOfRevenue | 1.88K | 6.08K | 2.80K | 7.89K |
| TotalRevenue | 4.35K | 18.60K | 5.15K | 14.37K |
| OperatingRevenue | 4.35K | 18.60K | 5.15K | 14.37K |
| Line Item | 2023-04-30 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 1.12M | 676.60K | 101.18K | 81.12K |
| ShareIssued | 1.12M | 676.60K | 101.18K | 81.12K |
| NetDebt | 1.45M | 5.15M | 2.16M | |
| TotalDebt | 2.99M | 1.04M | 1.57M | 6.16M |
| TangibleBookValue | -1.41M | 5.73M | 230.18K | -6.06M |
| InvestedCapital | 2.76M | 7.82M | 1.23M | 15.53K |
| WorkingCapital | -1.53M | 5.60M | 863.69K | -1.54M |
| NetTangibleAssets | -1.41M | 5.73M | 230.56K | -6.06M |
| CapitalLeaseObligations | 434.05K | 536.34K | 565.87K | 90.97K |
| CommonStockEquity | 204.79K | 7.32M | 230.18K | -6.06M |
| PreferredStockEquity | 380.00 | 380.00 | 381.00 | 483.00 |
| TotalCapitalization | 205.17K | 7.32M | 730.56K | -1.61M |
| TotalEquityGrossMinorityInterest | 205.17K | 7.32M | 230.56K | -6.06M |
| StockholdersEquity | 205.17K | 7.32M | 230.56K | -6.06M |
| RetainedEarnings | -76.13M | -67.36M | -60.76M | -54.40M |
| AdditionalPaidInCapital | 76.33M | 74.68M | 60.99M | 48.34M |
| CapitalStock | 1.50K | 1.06K | 482.00 | 3.81K |
| CommonStock | 1.12K | 677.00 | 101.00 | 3.32K |
| PreferredStock | 380.00 | 380.00 | 381.00 | 483.00 |
| TotalLiabilitiesNetMinorityInterest | 4.02M | 2.19M | 3.06M | 8.15M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 314.53K | 434.05K | 1.22M | 4.67M |
| NonCurrentAccruedExpenses | 0.00 | 187.45K | 232.87K | 132.23K |
| LongTermDebtAndCapitalLeaseObligation | 314.53K | 434.05K | 1.04M | 4.44M |
| LongTermCapitalLeaseObligation | 314.53K | 434.05K | 536.34K | 0.00 |
| LongTermDebt | 500.00K | 4.44M | 2.50M | |
| CurrentLiabilities | 3.70M | 1.75M | 1.83M | 3.47M |
| OtherCurrentLiabilities | 29.93K | 34.15K | 48.60K | 1.22K |
| CurrentDebtAndCapitalLeaseObligation | 2.67M | 602.29K | 529.53K | 1.72M |
| CurrentCapitalLeaseObligation | 119.52K | 102.29K | 29.54K | 90.97K |
| CurrentDebt | 2.55M | 500.00K | 500.00K | 1.63M |
| OtherCurrentBorrowings | 2.55M | 500.00K | 500.00K | 1.63M |
| PayablesAndAccruedExpenses | 1.00M | 1.12M | 1.25M | 1.75M |
| CurrentAccruedExpenses | 683.93K | 667.14K | 623.39K | 1.05M |
| InterestPayable | 177.63K | 268.81K | 237.53K | |
| Payables | 318.66K | 448.18K | 631.37K | 694.75K |
| AccountsPayable | 318.66K | 448.18K | 631.37K | 694.75K |
| TotalAssets | 4.22M | 9.50M | 3.29M | 2.09M |
| TotalNonCurrentAssets | 2.05M | 2.15M | 590.65K | 158.57K |
| GoodwillAndOtherIntangibleAssets | 1.62M | 1.59M | 0.00 | |
| NetPPE | 435.18K | 559.97K | 590.65K | 158.57K |
| AccumulatedDepreciation | -537.36K | -499.76K | -471.87K | -444.95K |
| GrossPPE | 972.53K | 1.06M | 1.06M | 603.52K |
| Leases | 32.81K | 32.81K | 32.81K | 32.81K |
| OtherProperties | 837.16K | 924.36K | 927.14K | 468.15K |
| MachineryFurnitureEquipment | 102.56K | 102.56K | 102.56K | 102.56K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 2.17M | 7.35M | 2.70M | 1.93M |
| OtherCurrentAssets | 40.37K | 40.37K | 40.37K | 40.37K |
| CurrentDeferredAssets | 290.93K | 692.99K | 175.92K | 246.40K |
| PrepaidAssets | 87.44K | 183.70K | 143.46K | 49.38K |
| Inventory | 650.27K | 629.18K | 676.36K | 674.14K |
| InventoriesAdjustmentsAllowances | -85.58K | -85.58K | -44.48K | -81.45K |
| FinishedGoods | 44.07K | 22.58K | 28.66K | 28.66K |
| WorkInProcess | 21.74K | 21.74K | 21.74K | 21.74K |
| RawMaterials | 670.03K | 670.43K | 670.43K | 705.18K |
| Receivables | 4.35K | 0.00 | 0.00 | 2.32K |
| AccountsReceivable | 4.35K | 0.00 | 0.00 | 2.32K |
| CashCashEquivalentsAndShortTermInvestments | 1.10M | 5.81M | 1.66M | 918.26K |
| CashAndCashEquivalents | 1.10M | 5.81M | 1.66M | 918.26K |
| Line Item | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
| FreeCashFlow | -7.44M | -6.20M | -5.79M | -3.65M |
| RepaymentOfDebt | -264.25K | -291.62K | -398.26K | -500.00K |
| IssuanceOfDebt | 1.85M | 334.25K | 0.00 | 4.73M |
| IssuanceOfCapitalStock | 1.15M | 10.30M | 5.62M | 0.00 |
| CapitalExpenditure | -30.19K | -125.27K | -18.31K | -1.93K |
| EndCashPosition | 1.10M | 5.81M | 1.66M | 918.26K |
| BeginningCashPosition | 5.81M | 1.66M | 918.26K | 723.48K |
| ChangesInCash | -4.71M | 4.15M | 742.21K | 194.78K |
| FinancingCashFlow | 2.73M | 10.34M | 6.53M | 3.84M |
| CashFlowFromContinuingFinancingActivities | 2.73M | 10.34M | 6.53M | 3.84M |
| NetOtherFinancingCharges | -385.14K | |||
| ProceedsFromStockOptionExercised | 0.00 | 1.31M | 0.00 | |
| NetPreferredStockIssuance | 0.00 | 200.00K | ||
| PreferredStockIssuance | 0.00 | 200.00K | ||
| NetCommonStockIssuance | 1.15M | 10.30M | 5.62M | 0.00 |
| CommonStockIssuance | 1.15M | 10.30M | 5.62M | 0.00 |
| NetIssuancePaymentsOfDebt | 1.59M | 42.62K | -398.26K | 4.23M |
| NetShortTermDebtIssuance | 0.00 | 250.20K | ||
| ShortTermDebtIssuance | 0.00 | 250.20K | ||
| NetLongTermDebtIssuance | 1.59M | 42.62K | -398.26K | 4.23M |
| LongTermDebtPayments | -264.25K | -291.62K | -398.26K | -500.00K |
| LongTermDebtIssuance | 1.85M | 334.25K | 0.00 | 4.73M |
| InvestingCashFlow | -30.19K | -125.27K | -18.31K | -1.93K |
| CashFlowFromContinuingInvestingActivities | -30.19K | -125.27K | -18.31K | -1.93K |
| NetIntangiblesPurchaseAndSale | -27.03K | -60.82K | 0.00 | |
| PurchaseOfIntangibles | -27.03K | -60.82K | 0.00 | |
| NetPPEPurchaseAndSale | -3.16K | -64.45K | -18.31K | -1.93K |
| SaleOfPPE | 0.00 | |||
| PurchaseOfPPE | -3.16K | -64.45K | -18.31K | -1.93K |
| OperatingCashFlow | -7.41M | -6.07M | -5.77M | -3.64M |
| CashFlowFromContinuingOperatingActivities | -7.41M | -6.07M | -5.77M | -3.64M |
| ChangeInWorkingCapital | 517.89K | -504.36K | 65.45K | 1.12M |
| ChangeInOtherWorkingCapital | 402.06K | -517.07K | 60.43K | -246.40K |
| ChangeInOtherCurrentLiabilities | -103.51K | -29.53K | -108.54K | 0.00 |
| ChangeInOtherCurrentAssets | 0.00 | |||
| ChangeInPayablesAndAccruedExpense | -112.73K | -241.88K | -272.32K | 1.22M |
| ChangeInAccruedExpense | 16.79K | -58.69K | -310.15K | 865.34K |
| ChangeInPayable | -129.52K | -183.19K | 37.82K | 358.96K |
| ChangeInAccountPayable | -129.52K | -183.19K | 37.82K | 358.96K |
| ChangeInPrepaidAssets | 357.51K | 236.93K | 385.77K | 72.52K |
| ChangeInInventory | -21.09K | 47.18K | -2.22K | 76.64K |
| ChangeInReceivables | -4.35K | 0.00 | 2.32K | -2.32K |
| ChangesInAccountReceivables | -4.35K | 0.00 | 2.32K | -2.32K |
| OtherNonCashItems | 456.51K | 539.23K | 131.51K | 191.72K |
| StockBasedCompensation | 249.88K | 405.02K | 248.31K | 68.40K |
| DepreciationAmortizationDepletion | 127.96K | 95.13K | 135.45K | 26.57K |
| DepreciationAndAmortization | 127.96K | 95.13K | 135.45K | 26.57K |
| AmortizationCashFlow | 0.00 | 644.00 | ||
| AmortizationOfIntangibles | 0.00 | 644.00 | ||
| Depreciation | 127.96K | 95.13K | 135.45K | 26.57K |
| OperatingGainsLosses | -227.31K | -248.54K | ||
| GainLossOnInvestmentSecurities | 22.89K | |||
| GainLossOnSaleOfPPE | 0.00 | 1.66K | ||
| NetIncomeFromContinuingOperations | -8.77M | -6.61M | -6.35M | -4.83M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for HSCS
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|